The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
10x Genomics, Inc. CL A COM 88025u109   20,077,495 359,554 SH   SOLE   20,077,495 0 0
Aadi Bioscience, Inc. COM 00032Q104   3,600,090 526,329 SH   SOLE   3,600,090 0 0
Adicet Bio, Inc. COM 007002108   1,228,773 505,668 SH   SOLE   1,228,773 0 0
Alpine Immune Sciences, Inc. COM 010392595   68,961,201 6,708,288 SH   SOLE   68,961,201 0 0
Apexigen, Inc. COM 03759B102   814,278 1,894,551 SH   SOLE   814,278 0 0
Arcus BioSciences, Inc. COM 03969f109   17,665,435 869,790 SH   SOLE   17,665,435 0 0
Argenx SE SHS 04016x101   10,689,904 27,429 SH   SOLE   10,689,904 0 0
AtriCure Inc. COM 004963C20   2,283,344 46,259 SH   SOLE   2,283,344 0 0
Aura Biosciences, Inc. COM 05153U107   3,622,663 293,333 SH   SOLE   3,622,663 0 0
BeyondSpring Inc. SHS 00BD36JB9   5,850,609 4,958,143 SH   SOLE   5,850,609 0 0
Cue Health Inc. COM 229790100   3,322,936 8,980,909 SH   SOLE   3,322,936 0 0
Equillium Inc. COM 29446K106   3,335,481 4,447,308 SH   SOLE   3,335,481 0 0
Horizon Therapeutics PLC COM G46188101   8,114,865 78,900 SH   SOLE   8,114,865 0 0
Illumnia, Inc. COM 452327109   15,160,254 80,859 SH   SOLE   15,160,254 0 0
Mersana Therapeutics, Inc. COM 59045L106   2,975,042 904,268 SH   SOLE   2,975,042 0 0
NeuBase Therapeutics, Inc. COM 64132K102   92,500 50,000 SH   SOLE   92,500 0 0
Pacific Biosciences of California, Inc. COM 69404D108   19,469,498 1,463,872 SH   SOLE   19,469,498 0 0
Scynexis Inc. COM NEW 811292200   1,638,887 555,555 SH   SOLE   1,638,887 0 0
Seagen Inc. COM 812578102   4,429,274 23,014 SH   SOLE   4,429,274 0 0
GeneDx Holdings Corp. COM CL A 81663L101   617,479 103,604 SH   SOLE   617,479 0 0
Terns Pharmaceuticals, Inc. COM 880881107   6,249,994 714,285 SH   SOLE   6,249,994 0 0
Zentalis Pharmaceuticals Inc. COM 98943L107   59,229,236 2,099,583 SH   SOLE   59,229,236 0 0
PHATHOM PHARMACEUTICALS INC COM 71722W107   12,172,000 850,000 SH   SOLE   12,172,000 0 0
ROIVANT SCIENCES LTD COM 00BMW4NZ9   14,713,776 1,459,700 SH   SOLE   14,713,776 0 0
ACELYRIN INC(NSM) COM 00445A100   32,487,315 1,554,417 SH   SOLE   32,487,315 0 0